The Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin as a Primary Treatment for Dyslipidemia in Renal Transplant Recipients
Author:
Affiliation:
1. Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
Publisher
Korean Association of Internal Medicine
Link
http://synapse.koreamed.org/pdf/10.3904/kjim.2009.24.3.233
Reference28 articles.
1. Post-transplant hyperlipidemia: mechanisms and management.
2. Cardiovascular Risk and Renal Transplantation: Post Hoc Analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study
3. Cardiovascular disease after renal transplantation.
4. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
5. Effect of simvastatin on cyclosporine unbound fraction and apparent blood clearance in heart transplant recipients
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Promoting cardiovascular health post‐transplant through early diagnosis and adequate management of hypertension and dyslipidemia;Pediatric Transplantation;2020-09
2. Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID);Nutrition, Metabolism and Cardiovascular Diseases;2020-08
3. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology;Journal of Nephrology;2020-02-17
4. Role of Primary Care Provider in the Referral and Care of Thoracic Organ Transplant Patients;Textbook of Organ Transplantation;2014-07-25
5. Cyclosporin A-Induced Hyperlipidemia;Lipoproteins - Role in Health and Diseases;2012-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3